Vicarious Surgical RBOT
OTC RBOT
$0.05 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Vicarious Surgical (RBOT) Liabilities and Shareholders Equity (2020 - 2025)

Vicarious Surgical's (RBOT) quarterly Liabilities and Shareholders Equity came in at $19.6 million in Q4 2025, down 71.08% year-over-year from $67.7 million in Q4 2024, and down 33.28% quarter-over-quarter from $29.3 million in Q3 2025.

Analysis

Vicarious Surgical (RBOT) Liabilities and Shareholders Equity (2020 - 2025) Analysis & Trends

Vicarious Surgical (RBOT) has reported Liabilities and Shareholders Equity for 6 consecutive years, with $19.6 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 71.08% year-over-year to $19.6 million in Q4 2025; TTM through Dec 2025 was $144.9 million, a 58.25% decrease from a year earlier, with the FY2025 full-year figure at $19.6 million, down 71.08% from the prior year.
  • Liabilities and Shareholders Equity was $19.6 million for Q4 2025 at Vicarious Surgical, down from $29.3 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $346.4 million in Q1 2021 and troughed at $19.6 million in Q4 2025.
  • A 5-year average of $133.6 million and a median of $120.5 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity soared 89224.63% in 2021 and slumped 71.08% in 2025, its largest moves.
  • Over 5 years, Liabilities and Shareholders Equity stood at $181.7 million in 2021, then declined by 22.78% to $140.3 million in 2022, then slipped by 14.56% to $119.9 million in 2023, then plunged by 43.5% to $67.7 million in 2024, then slumped by 71.08% to $19.6 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $19.6 million (Q4 2025), $29.3 million (Q3 2025), and $40.9 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 109.22 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 20.88 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 93.31 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 47.93 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 13.87 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 31.10 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 6.46 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 10.74 Bn
10 Vicarious Surgical 231,626.35 -14.81 Mn - 19.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 19.58 Mn
Sep 30, 2025 29.35 Mn
Jun 30, 2025 40.89 Mn
Mar 31, 2025 55.05 Mn
Dec 31, 2024 67.72 Mn
Sep 30, 2024 80.62 Mn
Jun 30, 2024 93.35 Mn
Mar 31, 2024 105.29 Mn
Dec 31, 2023 119.86 Mn
Sep 30, 2023 132.05 Mn
Jun 30, 2023 104.53 Mn
Mar 31, 2023 121.09 Mn
Dec 31, 2022 140.29 Mn
Sep 30, 2022 150.68 Mn
Jun 30, 2022 164.05 Mn
Mar 31, 2022 179.97 Mn
Dec 31, 2021 181.68 Mn
Sep 30, 2021 193.36 Mn
Jun 30, 2021 345.54 Mn
Mar 31, 2021 346.35 Mn